Introduction to Clinical Trials

1 July 2021

Summer School Webinar in collaboration with Treat-NMD

This webinar will cover the features of Clinical Trials, in particular the ones for Rare Diseases. Setting up Clinical Trials to populations with specific diseases of low prevalence is a skill of the John Walton Muscular Dystrophy Centre and Dr Guglieri has a vast experience running Clinical Trials and coordinating a team of healthcare providers, project managers and researchers with diverse skills to deliver the results that patients require to improve their care.

Michela Guglieri,  is a Senior Clinical Lecturer and Consultant Neurologist at Newcastle University and Newcastle Hospitals NHS Foundation Trust. Michela has a specific interest in care, management and translational research in inherited neuromuscular disorders. Michela has been involved in several clinical trials in Duchenne muscular dystrophy (DMD) and other neuromuscular disorders and is study chair for two large international trials in DMD.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern